IQOS launched for sale in the US market

PinterestFacebookTwitterShare

Foto: Philip Morris

Philip Morris has announced that IQOS, electrically heated tobacco system, has been launched for sale in the United States. Philip Morris International is bringing IQOS to the U.S. market through an exclusive licensing agreement with Altria Group, Inc. The launch of IQOS in the United States, by opening the first store in Atlanta, is a historic milestone in delivering new choices for adult smokers, as IQOS is the first electrically heated tobacco technology to be authorized for sale by the U.S. Food and Drug Administration (FDA). „Adult smokers deserve access to innovative smoke-free alternatives, as well as to accurate information about these products. With a combination of stringent but sensible regulation, rigorous assessment, greater awareness and regulated marketing activities, smoke-free products can play a pivotal role in helping adults who would otherwise continue to smoke cigarettes to switch to smoke – free alternatives”, claimed Aleksandar Jakovljević, managing director of Philip Morris for SEE markets. The launch of IQOS in the United States is further proof of Filip Morris’s commitment to encourage adult smokers to switch to smoke-free products driven by innovation and scientific research. It Its pioneering character is reflected in the fact that, to date, no other electrically heated tobacco product has been authorized for sale by the U.S. FDA.  IQOS is the first electronic device with heat not burn technology to be authorized for sale by the US Food and Drug Administration, which in April confirmed that its sales, if conducted in accordance with established marketing guidelines, are in compliance with public health protection. The agency’s decision followed a comprehensive scientific assessment of PMI’s premarket tobacco product applications (PMTAs) submitted to the agency in 2017. In addition, Philip Morris International has submitted a comprehensive body of scientific evidence in support of a parallel set of applications for IQOS to be authorized as a modified risk tobacco product (MRTP), which the FDA continues to review. This is another step towards a smoke-free world, which Philip Morris is committed to.

Izvor: BIZLife

Foto: Philip Morris